1.
Eichenfeld L, Simpson E, Papp K, Szepietowski J, Kircik L, Toth D, Forman S, Kuligowski M, Venturanza M, Ren H, Paller A. Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies. J of Skin [Internet]. 2022Mar.4 [cited 2023Jan.26];6(2):s28. Available from: https://jofskin.org/index.php/skin/article/view/1545